Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 772
Guide Official Revision Description Reason for Update
Version Date Number Of Change
eligibility letter or warning
letter.
2026 09/30/2026 21 Medical Policy In Substances of
Dependence/Abuse added
new Drug Use Personal
Statement template.
2026 09/30/2026 22 Medical Policy In Substances of
Dependence/Abuse added
new Substance Use
Disorders (DSM);Substance
Abuse or Substance
Dependence (DSM or CFR)
Disposition Table
(e.g. Positive DOT or FAA
alcohol or drug test; Failed
alcohol or drug test; yes to
18n or 18o; or medical
complications associated
with drug/alcohol).
2026 09/30/2026 23 Medical Policy In Substances of
Dependence/Abuse (Drugs
and Alcohol), revised FAA
Certification Aid – Drug and
Alcohol INITIAL
to link to DUI/DWI or Drug
Use Personal Statement
2026 09/30/2026 24 Medical Policy In Pharmaceuticals,
Antihypertensive Medication,
added link to Item 46,
Neurologic - Headaches -
Migraine, CACI and AASI.
Removed reserpine. Added
(HTN, blood pressure
medication) to title.
2026 09/30/2026 25 Medical Policy In Pharmaceuticals, Do Not
Issue/Do Not Fly, removed
reserpine as no longer
available in the US.
2026 09/30/2026 26 Medical Policy In Pharmaceuticals, revised
Acceptable Combinations of
Diabetes Medications, to
clarify within Group A1,
adding new type of insulin, 7
day observation time.
2026 09/30/2026 27 Medical Policy In Pharmaceuticals, updated
Allergy – Antihistamine &
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
